Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001395064-25-000138·HilleVax, Inc.
Schedule 13D ownership disclosure
HILLEVAX INC
Common Stock, par value $0.0001 per share · CUSIP: 43157M102
Event date: 2025-09-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Takeda Pharmaceutical Company LimitedReported CIK 0001395064
Shares: 0.00 · Class: 0.0%
- Takeda Vaccines Inc.Reported CIK 0001905616
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001395064-25-000138
- Form type
- SCHEDULE 13D/A
- Filer
- HilleVax, Inc.
- CIK
- CIK 1888012
- Filed
- Sep 19, 2025
- Reporting period
- Sep 17, 2025
- Description
- Schedule 13D beneficial ownership